Skip to content

ARTIVION, INC.

AORT · XNYS

CIK 784199fmd_0M3J1JZ20ZSZ33976PZVA593BMManufacturing · Surgical & Medical Instruments & ApparatusTemplate: Standard

Coverage: Jan 01, 2009 to Sep 30, 2026, 68 periods

Income Statement · Annual · Millions · USD
Line itemFY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Total revenues180190263276253299314354389441
Cost of revenue6161909385101111125140157
Gross profit119129173183168198203229249284
Realized investment gains (losses)0000000000
Research and development13192323243639292831
Selling, general and administrative92101141143141170157209181226
Total operating expenses105121164166165205196238210257
Operating income22891728663934
Interest expense351615171718253427
Interest and investment income0001000111
Other non-operating income (expense)(0)0(0)(1)(3)(6)(3)(3)(10)10
Income before taxes184(6)2(17)(15)(15)(22)(8)15
Income tax expense8(0)(4)(0)(0)04965
Net income from continuing operations114(3)2(17)(15)(19)(31)(13)10
Net income114(3)2(17)(15)(19)(31)(13)10
Net income to common shareholders114(3)2(17)(15)(19)(31)(13)10
ARTIVION, INC. (AORT) financial statements · FinancialMD